Reproduction and Gynecological Cancers

Kirsten Tryde Macklon

doi:10.1055/s-0045-1811634

Seminars in Reproductive Medicine, Inhaltsverzeichnis

Semin Reprod Med 2025; 43(01): 003-004
DOI: 10.1055/s-0045-1811634

Preface

Reproduction and Gynecological Cancers

Authors

Kirsten Tryde Macklon

¹Department of Gynecology, Fertility and Obstetrics, Fertility Clinic, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Abstract

Volltext

Referenzen

References
1 Poorvu PD, Frazier AL, Feraco AM. et al. Cancer treatment-related infertility: a critical review of the evidence. JNCI Cancer Spectr 2019; 3 (01) pkz008
2 Rozen G, Rogers P, Chander S. et al. Clinical summary guide: reproduction in women with previous abdominopelvic radiotherapy or total body irradiation. Hum Reprod Open 2020; 2020 (04) hoaa045
3 Meirow D, Biederman H, Anderson RA, Wallace WHB. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 2010; 53 (04) 727-739
4 Letourneau JM, Ebbel EE, Katz PP. et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer 2012; 118 (06) 1710-1717
5 Deshpande NA, Braun IM, Meyer FL. Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: a systematic review. Cancer 2015; 121 (22) 3938-3947
6 Ussher JM, Perz J. Australian Cancer and Fertility Study Team (ACFST). Threat of biographical disruption: the gendered construction and experience of infertility following cancer for women and men. BMC Cancer 2018; 18 (01) 250
7 Crawshaw MA, Sloper P. “Swimming against the tide”—the influence of fertility matters on the transition to adulthood or survivorship following adolescent cancer. Eur J Cancer Care (Engl) 2010; 19 (05) 610-620
8 Rodolakis A, Scambia G, Planchamp F. et al. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma. Hum Reprod Open 2023; 2023 (01) hoac057
9 Morice P, Scambia G, Abu-Rustum NR. et al. Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE. Lancet Oncol 2024; 25 (11) e602-e610